SCHEMBL6601541

SCHEMBL6601541

CN1CCCCC1COc1ccc(C(=O)c2c(-c3ccc(O)cc3)sc3cc(O)ccc23)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 20/20 0.68
ESR2 Q92731 19/20 0.68
MEN1 O00255 2/20 0.67
ALDH1A1 P00352 2/20 0.67
LMNA P02545 2/20 0.67
TP53 P04637 2/20 0.67
CYP3A4 P08684 2/20 0.67
MAPT P10636 2/20 0.67
ALOX15 P16050 2/20 0.67
KMT2A Q03164 2/20 0.67
HSD17B10 Q99714 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
PLD2 O14939 1/20 0.67
KDM1A O60341 1/20 0.67
NR1I2 O75469 1/20 0.67
USP2 O75604 1/20 0.67
C5 P01031 1/20 0.67
FYN P06241 1/20 0.67
PGR P06401 1/20 0.67
ADRA2A P08913 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6836553 0.90 ESR1 (0.64) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL6601788 0.89 ESR1 (0.69) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL6603713 0.89 ESR1 (0.61) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL6600959 0.87 ESR1 (0.61) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL7070769 0.86 ENPP3 (0.63) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL6836603 0.85 ESR1 (0.60) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL6603230 0.84 ESR1 (0.66) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL7773955 0.83 ESR1 (0.74) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL6604676 0.81 ESR1 (0.66) ESR1ESR2MEN1ALDH1A1LMNA
Ly-117018 SCHEMBL29417500 0.81 ESR1 (1.00) ESR1ESR2MEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5589482-A Benzo-thiophene estrogen agonists to treat prostatic hyperplasia PFIZER INC. (US) 1996-12-31 US claimed
EP-0723537-A1 BENZOTHIOPHENES AND RELATED COMPOUNDS AS ESTROGEN AGONISTS PFIZER INC. (US) 1996-07-31 EP claimed
EP-0716855-A2 Use of estrogen agonists for treating prostatic disease, obesity and bone loss PFIZER INC. (US) 1996-06-19 EP claimed
WO-1995010513-A1 BENZOTHIOPHENES AND RELATED COMPOUNDS AS ESTROGEN AGONISTS PFIZER INC. (US) 1995-04-20 WO claimed
EP-0905132-B1 Benzothiophenes LILLY CO ELI (US) 2004-08-04 EP disclosed
US-6756388-B1 HAVING PIPERIDINYL AND PHENOLIC FUNCTIONALITY; BONE LOSS; BREAST OR PROSTATE CANCER PFIZER INC. 2004-06-29 US disclosed
US-6060488-A ANTICARCINOGENIC AGENTS; POSTMENOPAUSAL CANCER OF BREASTS, UTERUS, CERVIX ELI LILLY AND COMPANY (US) 2000-05-09 US disclosed
EP-0905132-A1 Benzothiophenes ELI LILLY AND COMPANY (US) 1999-03-31 EP disclosed
EP-0723537-A1 BENZOTHIOPHENES AND RELATED COMPOUNDS AS ESTROGEN AGONISTS PFIZER INC. (US) 1996-07-31 EP disclosed
WO-1995010513-A1 BENZOTHIOPHENES AND RELATED COMPOUNDS AS ESTROGEN AGONISTS PFIZER INC. (US) 1995-04-20 WO disclosed